These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 21815904)
1. Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes. Xu X; Shi Y; Cui Y; Ma J; Che L; Chen ZJ Clin Endocrinol (Oxf); 2012 Mar; 76(3):425-30. PubMed ID: 21815904 [TBL] [Abstract][Full Text] [Related]
2. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
3. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome. Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Androgen Levels, Endocrine and Metabolic Indices, and Clinical Findings in Women with Polycystic Ovary Syndrome in Uygur and Han Ethnic Groups from Xinjiang Province in China. Zhao H; Song X; Zhang L; Xu Y; Wang X Med Sci Monit; 2018 Sep; 24():6774-6780. PubMed ID: 30252834 [TBL] [Abstract][Full Text] [Related]
5. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Barber TM; Wass JA; McCarthy MI; Franks S Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468 [TBL] [Abstract][Full Text] [Related]
6. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases]. Song J; Shen H; Li J; Huang Z; Zhang Y Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071 [TBL] [Abstract][Full Text] [Related]
7. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea. Guo M; Chen ZJ; Eijkemans MJ; Goverde AJ; Fauser BC; Macklon NS Hum Reprod; 2012 May; 27(5):1481-8. PubMed ID: 22402209 [TBL] [Abstract][Full Text] [Related]
9. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations. Koo YA; Shin SY; Yoon BK; Choi D Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414 [TBL] [Abstract][Full Text] [Related]
10. The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome. Yin D; Ruan X; Tian X; Du J; Zhao Y; Cui Y; Li Y; Mueck AO Gynecol Endocrinol; 2017 Apr; 33(4):332-335. PubMed ID: 28051891 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of abdominal acupuncture for patients with obesity-type polycystic ovary syndrome: a randomized controlled trial. Zheng YH; Wang XH; Lai MH; Yao H; Liu H; Ma HX J Altern Complement Med; 2013 Sep; 19(9):740-5. PubMed ID: 23676106 [TBL] [Abstract][Full Text] [Related]
12. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women? Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816 [TBL] [Abstract][Full Text] [Related]
13. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Holte J; Bergh T; Berne C; Lithell H Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457 [TBL] [Abstract][Full Text] [Related]
14. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome. Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502 [TBL] [Abstract][Full Text] [Related]
15. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J; Bergh T; Gennarelli G; Wide L Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458 [TBL] [Abstract][Full Text] [Related]
16. [Effect of abdominal acupuncture therapy on the endocrine and metabolism in obesity-type polycystic ovarian syndrome patients]. Lai MH; Ma HX; Yao H; Liu H; Song XH; Huang WY; Wu XK Zhen Ci Yan Jiu; 2010 Aug; 35(4):298-302. PubMed ID: 21090334 [TBL] [Abstract][Full Text] [Related]
17. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276 [TBL] [Abstract][Full Text] [Related]
18. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria. Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802 [TBL] [Abstract][Full Text] [Related]
19. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome]. Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620 [TBL] [Abstract][Full Text] [Related]
20. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome. Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]